Literature DB >> 213391

Peritoneal macrophage activation indicated by enhanced chemiluminescence.

C J Schleupner, L A Glasgow.   

Abstract

A number of studies have demonstrated the ability of various bacterial preparations, protozoa, and chemicals to activate macrophages and concomitantly to enhance host resistance to both tumors and infections. Recently, viral infections have been shown to have a similar effect upon macrophage function. To better define the metabolic state of activated macrophages, we have evaluated the ability of peritoneal cells (PC) from vaccinia virus- or murine cytomegalovirus-infected or Corynebacterium parvum-treated mice to emit chemiluminescence (CL) during phagocytosis of zymosan particles or yeasts. PC from C. parvum-treated mice (1,400 microgram intraperitoneally) emitted enhanced CL over controls on days 3, 6, 14, and 21 after treatment, thereby establishing the emission of CL as a correlate of metabolic activation. Previous evidence for activation of PC from vaccinia virus-infected mice (10(8) plaque-forming units) was confirmed by demonstration of enhanced levels of CL on days 3, 6, and 13 after murine infection. Likewise, PC from mice infected with murine cytomegalovirus (10(5) plaque-forming units) 3, 6, or 13 days previously demonstrated augmented levels of CL over controls. Opsonized virus particles (vaccinia virus or murine cytomegalovirus) failed to induce the emission of CL with PC from mice infected with the isologous virus. Our data further demonstrate the immunomodulationinduced by virus infections and suggest that the detection of CL is an easily quantitated correlate of macrophage activation which may be helpful in defining metabolic alterations induced during activation.

Entities:  

Mesh:

Year:  1978        PMID: 213391      PMCID: PMC422080          DOI: 10.1128/iai.21.3.886-895.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Supravital blood studies, using acridine orange fluorescence.

Authors:  J F JACKSON
Journal:  Blood       Date:  1961-05       Impact factor: 22.113

2.  Comparison of antiviral and antitumor activity of activated macrophages.

Authors:  P S Morahan; L A Glasgow; J L Crane; E R Kern
Journal:  Cell Immunol       Date:  1977-02       Impact factor: 4.868

3.  Immunomodulator-induced resistance against herpes simplex virus.

Authors:  P S Morahan; E R Kern; L A Glasgow
Journal:  Proc Soc Exp Biol Med       Date:  1977-04

4.  Chemiluminescence by human alveolar macrophages: stimulation with heat-killed bacteria or phorobol myristate acetate.

Authors:  G D Beall; J E Repine; J R Hoidal; F L Rasp
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

5.  Macrophage tumor killing: influence of the local environment.

Authors:  J B Hibbs; R R Taintor; H A Chapman; J B Weinberg
Journal:  Science       Date:  1977-07-15       Impact factor: 47.728

Review 6.  Corynebacterium parvum as an immunotherapeutic anticancer agent.

Authors:  M T Scott
Journal:  Semin Oncol       Date:  1974-12       Impact factor: 4.929

7.  Immunomodulation of host resistance to experimental viral infections in mice: effects of Corynebacterium acnes, Corynebacterium parvum, and Bacille calmette-guérin.

Authors:  L A Glasgow; J Fischbach; S M Bryant; E R Kern
Journal:  J Infect Dis       Date:  1977-05       Impact factor: 5.226

8.  Synergistic effect on mortality in mice with murine cytomegalovirus and Pseudomonas aeruginosa, Staphylococcus aureus, or Candida albicans infections.

Authors:  J R Hamilton; J C Overall; L A Glasgow
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

9.  Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence.

Authors:  V G Hemming; R T Hall; P G Rhodes; A O Shigeoka; H R Hill
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

10.  The adjuvant effect of Corynebacterium parvum: T-cell dependence of macrophage activation.

Authors:  V S Sljivić; S R Watson
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

View more
  18 in total

1.  Toxic oxygen metabolite production by circulating phagocytic cells in inflammatory bowel disease.

Authors:  J G Williams; L E Hughes; M B Hallett
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

2.  Chemiluminescence of asbestos-activated macrophages.

Authors:  K Donaldson; R T Cullen
Journal:  Br J Exp Pathol       Date:  1984-02

3.  Acquired chemotactic inhibitors during infection with guinea pig cytomegalovirus.

Authors:  R Tannous; M G Myers
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

4.  Adhesion of piliated Escherichia coli strains to phagocytes: differences between bacteria with mannose-sensitive pili and those with mannose-resistant pili.

Authors:  E Blumenstock; K Jann
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

5.  Enhancement of bronchoalveolar cell recovery and stimulation of alveolar macrophage chemiluminescence and resistance to influenza virus after treatment with RU 41821 aerosol.

Authors:  A Rudent; F Michel; C Labarre; A M Quero; R Zalisz; P Smets
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

6.  Comparison of immunomodulatory activities in mice and guinea pigs of a synthetic desmuramyl peptidolipid triglymyc.

Authors:  C D Leclerc; F M Audibert; L A Chedid; E J Deriaud; N K Masihi; E Lederer
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

7.  Neutrophil response and function during acute cytomegalovirus infection in guinea pigs.

Authors:  E L Yourtee; F J Bia; B P Griffith; R K Root
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

8.  Activity of phagocytic granulocytes in patients with prostatic cancer.

Authors:  R Hofmann; A Lehmer; J Braun; S Bauer
Journal:  Urol Res       Date:  1986

9.  Enhancement of neutrophils function as a result of prior exposure to chemotactic factor.

Authors:  D E Van Epps; M L Garcia
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

10.  1-Methylnicotinamide and nicotinamide: two related anti-inflammatory agents that differentially affect the functions of activated macrophages.

Authors:  Rafał Biedroń; Marta Ciszek; Marianna Tokarczyk; Małgorzata Bobek; Maria Kurnyta; Ewa M Słominska; Ryszard T Smoleński; Janusz Marcinkiewicz
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008-03-31       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.